Profile for Vertex Pharmaceuticals Incorporated (VRTX)

$ 278.095   6.095 (+2.24%) Volume: 895.01k 2:08 PM EDT 3-Aug-2020
Business Description:
Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.
Address: 50 Northern Avenue, Boston, MA, USA, 02210
Telephone: +1 617 341-6100 Website:
Facsimile: N/A Email: [email protected]
CEO: Reshma Kewalramani
Employees: 3,000 Market Cap: 72.1b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 875320
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)